Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,826,656
  • Shares Outstanding, K 140,404
  • Annual Sales, $ 983,710 K
  • Annual Income, $ -545,060 K
  • 60-Month Beta 1.63
  • Price/Sales 2.06
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NVAX with:

Options Overview Details

View History
  • Implied Volatility 138.20% ( -3.61%)
  • Historical Volatility 230.07%
  • IV Percentile 86%
  • IV Rank 71.50%
  • IV High 187.27% on 05/13/24
  • IV Low 15.11% on 11/28/23
  • Put/Call Vol Ratio 0.57
  • Today's Volume 36,174
  • Volume Avg (30-Day) 39,742
  • Put/Call OI Ratio 1.16
  • Today's Open Interest 411,914
  • Open Int (30-Day) 293,014

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.87
  • Number of Estimates 4
  • High Estimate -0.53
  • Low Estimate -1.23
  • Prior Year 0.58
  • Growth Rate Est. (year over year) -250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.81 +241.47%
on 04/18/24
15.00 -13.27%
on 05/14/24
+9.12 (+234.45%)
since 04/17/24
3-Month
3.81 +241.47%
on 04/18/24
15.00 -13.27%
on 05/14/24
+8.85 (+212.74%)
since 02/16/24
52-Week
3.53 +268.30%
on 02/05/24
15.00 -13.27%
on 05/14/24
+5.26 (+67.87%)
since 05/17/23

Most Recent Stories

More News
Is Novavax Stock a Buy?

Can Novavax's stock continue soaring?

NVAX : 13.01 (-9.65%)
Could Novavax Become the Next Moderna?

Sanofi believes in Novavax's vaccine strengths...

SNY : 48.67 (-0.31%)
PFE : 28.64 (-0.97%)
NVAX : 13.01 (-9.65%)
MRNA : 132.90 (+0.17%)
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now

This coronavirus vaccine maker entered the market behind rivals.

NVAX : 13.01 (-9.65%)
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?

A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy.

NVAX : 13.01 (-9.65%)
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

These two healthcare stocks may be deeply undervalued.

ETN : 330.24 (+0.02%)
CPRX : 16.49 (+0.55%)
NVAX : 13.01 (-9.65%)
SNY : 48.67 (-0.31%)
Novavax Stock Just Tripled. Is It Too Late to Buy?

Novavax shares have soared and plummeted in recent years.

SNY : 48.67 (-0.31%)
NVAX : 13.01 (-9.65%)
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?

Moderate success regarding a new licensing deal with Sanofi could make the troubled vaccine stock a top performer.

PFE : 28.64 (-0.97%)
NVAX : 13.01 (-9.65%)
SNY : 48.67 (-0.31%)
Why Novavax Stock More Than Doubled Today

A cloud of doubt hanging over the company just gave way to some sunshine.

NVAX : 13.01 (-9.65%)
SNY : 48.67 (-0.31%)
Stock Index Futures Climb as Fed Rate Cut Hopes Grow, Fed Speak and ECB Minutes in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.40%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.44% this morning after three major U.S. benchmark indices ended the regular session in the green...

ESM24 : 5,327.25s (+0.13%)
NQM24 : 18,635.25s (-0.08%)
EQIX : 799.83 (+0.04%)
APP : 82.49 (-0.89%)
AFRM : 33.83 (+8.01%)
EPAM : 187.80 (-0.71%)
ABNB : 145.66 (-1.04%)
IVG.M.DX : 11.440 (-1.04%)
ZAL.D.DX : 24.310 (-3.88%)
NVAX : 13.01 (-9.65%)
ARRY : 10.96 (-3.35%)
VSCO : 22.16 (+2.12%)
Novavax: Q1 Earnings Snapshot

Novavax: Q1 Earnings Snapshot

NVAX : 13.01 (-9.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 15.37
2nd Resistance Point 14.88
1st Resistance Point 13.94
Last Price 13.01
1st Support Level 12.51
2nd Support Level 12.02
3rd Support Level 11.08

See More

52-Week High 15.00
Last Price 13.01
Fibonacci 61.8% 10.62
Fibonacci 50% 9.27
Fibonacci 38.2% 7.91
52-Week Low 3.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar